SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.147
AS - Asia 5.724
EU - Europa 4.431
SA - Sud America 928
AF - Africa 140
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.393
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.948
SG - Singapore 2.203
PL - Polonia 1.760
CN - Cina 1.410
BR - Brasile 714
IT - Italia 651
VN - Vietnam 637
HK - Hong Kong 454
DE - Germania 447
UA - Ucraina 440
TR - Turchia 330
GB - Regno Unito 278
FR - Francia 197
FI - Finlandia 155
RU - Federazione Russa 149
BD - Bangladesh 124
IN - India 117
SE - Svezia 110
ID - Indonesia 96
JP - Giappone 92
AR - Argentina 89
CA - Canada 89
MX - Messico 78
NL - Olanda 60
ZA - Sudafrica 49
IQ - Iraq 45
BE - Belgio 37
EC - Ecuador 35
PK - Pakistan 31
SA - Arabia Saudita 31
CO - Colombia 30
AT - Austria 28
ES - Italia 25
MA - Marocco 22
PH - Filippine 20
LT - Lituania 19
AU - Australia 17
VE - Venezuela 17
CZ - Repubblica Ceca 16
KE - Kenya 16
MY - Malesia 16
CL - Cile 15
AE - Emirati Arabi Uniti 14
EG - Egitto 14
UZ - Uzbekistan 14
PY - Paraguay 12
RO - Romania 12
TN - Tunisia 12
IE - Irlanda 11
IL - Israele 10
IR - Iran 10
JO - Giordania 9
KZ - Kazakistan 9
LB - Libano 9
CH - Svizzera 8
PE - Perù 7
AL - Albania 6
CR - Costa Rica 6
JM - Giamaica 6
TH - Thailandia 6
ET - Etiopia 5
NP - Nepal 5
OM - Oman 5
PS - Palestinian Territory 5
UY - Uruguay 5
DZ - Algeria 4
GR - Grecia 4
KR - Corea 4
PA - Panama 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
BY - Bielorussia 3
GT - Guatemala 3
HN - Honduras 3
KH - Cambogia 3
MD - Moldavia 3
NG - Nigeria 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GA - Gabon 2
HU - Ungheria 2
LY - Libia 2
MG - Madagascar 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
ZW - Zimbabwe 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CD - Congo 1
CG - Congo 1
Totale 21.378
Salva come PNG Salva come JPEG
Città #
Warsaw 1.757
Singapore 1.286
Ashburn 1.154
Fairfield 948
Woodbridge 759
San Jose 757
Houston 560
Beijing 493
Santa Clara 448
Hong Kong 445
Jacksonville 402
Seattle 387
Chandler 369
Wilmington 344
Ann Arbor 342
Cambridge 328
Izmir 237
Ferrara 207
New York 198
Ho Chi Minh City 180
Princeton 173
Nanjing 164
Los Angeles 161
Dallas 158
Hanoi 151
The Dalles 122
Lauterbourg 119
San Diego 108
Munich 95
Tokyo 91
Council Bluffs 81
Milan 74
Shanghai 66
Helsinki 61
Jakarta 59
São Paulo 57
Bologna 47
London 46
Mexico City 44
Orem 43
Boardman 42
Buffalo 41
Nanchang 41
Da Nang 40
Tianjin 40
Shenyang 37
Brussels 36
Hebei 36
Rome 35
Dong Ket 34
Jiaxing 33
Montreal 33
Changsha 32
Chicago 32
Brooklyn 31
Chennai 28
Haiphong 28
San Francisco 28
Dearborn 27
Rio de Janeiro 27
Boston 26
Manchester 26
Nuremberg 26
Phoenix 26
Turku 25
Falls Church 24
Hefei 23
Stockholm 23
Atlanta 22
Norwalk 22
Belo Horizonte 21
Falkenstein 21
Frankfurt am Main 21
Jinan 21
Johannesburg 21
Mountain View 21
Amsterdam 20
Moscow 19
Poplar 19
Denver 18
Orange 18
Redwood City 17
Toronto 17
Baghdad 16
Porto Alegre 16
Kunming 15
San Mateo 15
Modena 14
Des Moines 13
Mumbai 13
Nairobi 13
Ankara 12
Auburn Hills 12
Brno 12
Ningbo 12
Ottawa 12
Washington 12
Bogotá 11
Brasília 11
Guangzhou 11
Totale 14.919
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 407
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 363
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 337
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 314
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 309
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 284
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 281
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 273
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 270
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 264
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 262
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 258
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 258
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 236
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 231
Recombinant herpes simplex virus and uses therefor 229
Nanoparticles for delivery of a pharmacologically active agent 226
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 224
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 208
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 201
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 201
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 197
Episomal DNA of a BK virus variant in a human insulinoma 196
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 194
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 192
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 189
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 188
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 187
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 187
Transformation of hamster kidney cells by fragments of BK virus DNA 185
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 185
null 183
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 183
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 182
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 181
null 179
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 177
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 177
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 176
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 169
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 168
null 167
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 167
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 164
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 164
The tat gene and protein of the human immunodeficiency virus type 1. 163
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 161
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 159
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation 152
Vaccines containing the HIV tat protein as an adjuvant for the enhancement of cytotoxic T-cell responses 152
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 148
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 147
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 145
Antiretroviral Therapy Partially Restores Phenotypic and Metabolic Immunosenescence Features of T Cells in Hiv Infected Individuals 144
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 141
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 141
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 140
Co-operation in cell transformation between BK virus and the human c-Harvey-ras oncogene 138
The HIV-1 regulatory genes tat and rev as targets for gene therapy 137
Presenza del virus BK in sarcomi di Kaposi. 137
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 137
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 135
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 132
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 132
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 131
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 130
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 130
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 129
Reexamination of the coding potential of the HTLV-1 pX region 128
Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region and the activated human c-Harvey-ras oncogene 127
Inhibition of HIV-1 tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity 127
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 127
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 126
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 126
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 126
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 123
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 122
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 122
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 120
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 120
Constitutive expression of hiv-1 tat protein in human jurkat t cells using a bk virus vector 120
ANTIRETROVIRAL THERAPY RESTORES NAÏVE T CELL FREQUENCIES OC 8 AND FUNCTIONALITY IN PLWH 119
Transformation of hamster kidney cells by a fragment of BK virus DNA containing the entire early region 119
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 119
New BK virus episomal vector for complementary DNA expression in human cells 117
Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL 116
Use of microparticles for antigen delivery 116
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 115
Novel Chitosan-Based Schiff Base Compounds: Chemical Characterization and Antimicrobial Activity 114
Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen 114
null 113
Oncogenicity of BK virus for immunosuppressed hamster 112
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 112
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 111
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 111
null 110
Factors afceting amplification of BK virus episomal vectors in human cells 110
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 109
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 109
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 107
Totale 17.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.263
Totale 101.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/20252.923 91 70 240 100 332 225 114 108 460 405 469 309
2025/20267.939 840 313 746 1.014 1.095 503 931 426 709 931 373 58
Totale 21.641